State Medicaid programs can struggle to balance their Medicaid
population health outcomes with growing pharmacy program
drug costs. Gainwell's dynamic and forward-looking approach
to developing effective Preferred Drug Lists (PDL) can help you
reduce overall pharmacy expenditures and provide the best
clinical value.
Formulary
management
optimized for
state-specific
economies
Our expansive approach to designing effective PDLs helps
states maximize drug rebate potential, lower pharmacy
program net expenditures and provide the best clinical
effectiveness to improve patient safety and outcomes.
